Shares of online pharmacy Hims & Hers (HIMS -7.77%) dropped as much as 12.8% on Thursday after a shortseller wrote a report about the company. Shares recovered slightly during trading and are down 7.8% at 2:30 p.m. ET today. The short-seller's report In this case, Hunterbrook criticized Hims & Hers' GLP-1 weight-loss treatment, which is a compound made by a pharmacy and temporarily approved to fill shortages of GLP-1 drugs, and not a government-approved medication itself. There are questions, even by the Fo ...